Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study

NCT06027333 is registered in ClinicalTrials.gov with Berner Reha Zentrum AG as lead sponsor.

NCT NCT06027333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study
Lead sponsor
Berner Reha Zentrum AG
Phase
Observational
Overall status
Recruiting
Start date
November 8, 2023
Completion date
August 30, 2028
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fibrotic lung disease, interstitial lung disease, patient education, quality of life, self efficacy, self-management